On 14th May Glycostem is going to present a poster at ASGCT 2020 about oNKord® “off-the-shelf” NK therapy closed system manufacturing process and clinical potential in AML, with a perspective on CAR-NK and other NK innovative therapies.
Glycostem will participate in Bio CEO on 10th and 11th February in New York. Glycostem’s CEO Troels Jordansen will provide an update on Glycostem.
Glycostem’s CEO Troels Jordansen will provide an update on Glycostem at Phacilitate Leaders World & World Stem Cell Summit 2020 between 21st and 24th January in Miami.
Glycostem will participate in BioTech Showcase from 13th to 15th January in San Francisco. Glycostem’s CEO Troels Jordansen will be available for networking and partner discussions.